** Shares of Anatara Lifesciences ANR.AX fall as much as 6.3% to A$0.015, their lowest since September 22

** Shares post biggest intraday pct fall since September 19

** Gastrointestinal health products maker receives firm commitments for A$1.2 million ($791,520) placement

** Issue price of A$0.012 represents a discount of 25% to stock's last close

** Proceeds to be used to fund ANR's current anti-obesity project and due diligence on other opportunities and assets

** Stock down 68.1% YTD, including session's moves

($1 = 1.5161 Australian dollars)

(Reporting by Anjali Singh in Bengaluru)

((anjali.singh2@thomsonreuters.com;))